Care gap reporting EHR: the screenings your reports are quietly missing
A care gap report is a set of intervals someone configured once. The intervals in the measures have moved twice since, and the report has no way of telling you it is now wrong.
The MIPS colorectal measure uses a nine-year colonoscopy lookback, not ten. Breast screening now runs from age 40, not 50. Colorectal now starts at 45. A care gap report built on the old numbers reports patients as compliant who are already gaps, and never flags a decade of eligible women.
Care gap reports fail quietly. That is what makes them dangerous.
A broken report throws an error. A stale report returns a clean list, every week, and nobody questions it, because a report that says there is nothing to do is exactly what everyone hopes to see. The intervals inside it were typed in when the report was built, and measure specifications have moved since.
Three of those movements are live right now in the 2026 measure specifications, and each one causes a different failure. One under-reports by a year. One misses a decade of eligible patients. One quietly redefines who is even in the denominator.
None of this needs new software. It needs somebody to open the specification and compare it against what the report is actually doing.
The colorectal screening lookback is nine years, not ten
This is the finding worth the whole article. The 2026 specification for the MIPS colorectal cancer screening measure sets modality-specific lookback windows, and the colonoscopy window is nine years prior to the measurement period, not ten.
Almost every care gap rule we look at is set to ten. The consequence is precise and one-directional: for a full year, patients who are already gaps under the measure are reported by the practice’s own system as compliant. They do not appear on an outreach list. Nobody calls them. And the practice discovers the discrepancy when its performance rate comes back lower than its internal report predicted.
The stool DNA window is the second surprise. Two years, not three. A practice that adopted sDNA-FIT on the understanding it bought three years of coverage is carrying a year of patients it believes are covered and the measure does not.
- Colonoscopy: 9 years, not 10. This one costs you a full year of gaps.
- sDNA-FIT: 2 years, not 3.
- Flexible sigmoidoscopy and CT colonography: 4 years each.
- FOBT: within the measurement period itself.
The breast cancer screening measure now starts at 40
The 2026 specification for the MIPS breast cancer screening measure covers women aged 40 to 74 who had a mammogram in the 27 months prior to the end of the measurement period. The denominator is women aged 41 to 74 with a visit during the measurement period.
A care gap rule still set to 50 to 74 is not producing a slightly shorter list. It is omitting an entire decade of patients from outreach, and those patients count against the practice in the denominator whether or not the report knows they exist. This is the failure mode that is hardest to notice from the inside, because the report looks healthy — it is simply answering a narrower question than the one being scored.
Note the deliberate one-year offset between the numerator age range and the denominator age range in the specification. That is not a typo in this article; it is how the measure is written, and a rule built by reading only the headline age range will get the denominator wrong.
Annual Wellness Visit requirements are where the schedule comes from
There is a reason care gaps and the Annual Wellness Visit belong in the same conversation. The visit is not only an opportunity to close gaps; the regulation requires it to produce the schedule the gaps are measured against.
42 CFR 410.15 defines the initial Annual Wellness Visit as fourteen enumerated elements. One of them is the establishment of a written screening schedule for the next five to ten years, based on United States Preventive Services Task Force and Advisory Committee on Immunization Practices recommendations. The subsequent visit is a shorter twelve-element service.
So the practice is already required to generate a forward screening schedule per patient. Where that schedule lives as unstructured text in a visit note rather than as structured data, the care gap report cannot see it, and the practice ends up maintaining two independent and silently divergent views of the same question. Three of the fourteen elements are conditional rather than universally required, which is worth knowing before anyone builds a checklist that treats all fourteen as mandatory.
The MIPS quality measure denominator is where exclusions hide
Both screening measures exclude the same cohorts, and the exclusions are more specific than most reports implement. Patients in hospice or receiving palliative care, long-term care residents aged 66 and over, and patients aged 66 and over with frailty plus either dementia medication or advanced illness are removed from the denominator.
Reports that do not implement these exclusions inflate the gap list with patients for whom outreach is inappropriate. That is not only a measurement problem. It is a clinical and a staff-time problem, and it is the reason gap lists get ignored: once a list contains people it obviously should not, the whole list loses credibility with the people meant to work it.
One thing we are not going to tell you: which reporting pathway these measures are available under in 2026. The specification indicated a restriction for one collection type and we did not separately confirm it against the measure inventory. Check that before building a reporting plan on it. Our MIPS and MACRA work starts from the inventory rather than from the specification for exactly this reason.
Sure your gap list matches the measure?
We will compare your care gap rules against the current specifications, field by field, and show you which intervals have moved underneath them.
Building an overdue screening report that stays right
The durable fix is not a better report. It is a review cadence, because the specifications are revised annually and the report has no mechanism for noticing.
Put the measure version and its publication date into the report definition itself, as a comment or a title. It costs nothing and it converts an invisible staleness problem into a visible one: anyone opening the report can see it was built against the December 2024 specification and that a newer one exists. That single change is worth more than any amount of care gap reporting EHR review after the fact.
Then check the four things that move most: age ranges, lookback windows, the exclusion logic, and whether the numerator accepts the modalities the practice actually uses. Those four cover nearly every stale-report failure we find. A broader EHR solutions engagement usually surfaces them as a side effect of quality reporting work, but they are worth a standing annual slot of their own.
Care gap reporting: common questions
Why does the colonoscopy lookback being nine years instead of ten matter so much?
Our breast screening report starts at 50. Is that wrong now?
Does the Annual Wellness Visit have to produce a screening schedule?
Why does our gap list include patients we should not be contacting?
Is there a HIPAA issue with running care gap reports and outreach?
Let’s meet
Qventive supports practice operations across New Jersey. Thirty years healthcare-exclusive, from our office in Hackensack.
- Colorectal cancer screening measure, ages 45 to 75, with modality-specific lookback windows including a nine-year colonoscopy window. qpp.cms.gov
- Breast cancer screening measure, women aged 40 to 74, mammogram within 27 months, denominator ages 41 to 74. qpp.cms.gov
- Fourteen elements of the initial Annual Wellness Visit, including a written five to ten year screening schedule. ecfr.gov
- Kidney health evaluation electronic clinical quality measure for the 2026 performance period. ecqi.healthit.gov